| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Shulamit B Wallach-Dayan | Q56241056 |
| P2093 | author name string | David Naor | |
| Muayad A Zahalka | |||
| Ronit Vogt Sionov | |||
| P433 | issue | 4 | |
| P304 | page(s) | 260-267 | |
| P577 | publication date | 2008-03-29 | |
| P1433 | published in | Seminars in Cancer Biology | Q1908668 |
| P1476 | title | Involvement of CD44, a molecule with a thousand faces, in cancer dissemination | |
| P478 | volume | 18 |
| Q93362411 | 1H, 15N, 13C resonance assignment of the human CD44 cytoplasmic tail (669-742) |
| Q33614637 | A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx |
| Q37327734 | A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation |
| Q37690517 | A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44. |
| Q52632017 | A novel monoclonal antibody KMP1 has potential antitumor activity of bladder cancer by blocking CD44 in vivo and in vitro. |
| Q43997484 | Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice |
| Q37236260 | Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival. |
| Q36111609 | Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1 |
| Q35545627 | Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression |
| Q39797784 | Anti-CD44 induces apoptosis in T lymphoma via mitochondrial depolarization |
| Q55084538 | Antibody-modified liposomes for tumor-targeting delivery of timosaponin AIII. |
| Q38097532 | Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma |
| Q93200108 | Binding of Targeted Semiconducting Photothermal Polymer Nanoparticles for Intraperitoneal Detection and Treatment of Colorectal Cancer |
| Q38788794 | CD44 Antibody Inhibition of Macrophage Phagocytosis Targets Fcγ Receptor- and Complement Receptor 3-Dependent Mechanisms. |
| Q42102048 | CD44 Expression in Meningioma and its Correlation with Proliferation Indices |
| Q92757813 | CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling |
| Q39040951 | CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549. |
| Q35292720 | CD44 and CD74: The promising candidates for molecular targeted therapy in oral squamous cell carcinoma |
| Q35376738 | CD44 and HCELL: preventing hematogenous metastasis at step 1. |
| Q34907133 | CD44 expression in curettage and postoperative specimens of endometrial cancer |
| Q33721902 | CD44 expression is developmentally regulated in the mouse lens and increases in the lens epithelium after injury. |
| Q37831812 | CD44 in hematological neoplasias |
| Q39467150 | CD44 is a biomarker associated with human prostate cancer radiation sensitivity |
| Q37145661 | CD44 receptor unfolding enhances binding by freeing basic amino acids to contact carbohydrate ligand |
| Q45406868 | CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma |
| Q28084610 | CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells |
| Q37851351 | CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? |
| Q38879479 | CD44S-hyaluronan interactions protect cells resulting from EMT against anoikis |
| Q33375699 | CD44s and CD44v6 expression in head and neck epithelia |
| Q30500172 | CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance |
| Q90672651 | CNTs mediated CD44 targeting; a paradigm shift in drug delivery for breast cancer |
| Q33550832 | CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells |
| Q57168005 | Cancer Cell Glycocalyx and Its Significance in Cancer Progression |
| Q34598261 | Cancer cell glycocalyx mediates mechanotransduction and flow-regulated invasion |
| Q35835166 | Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer |
| Q39428933 | Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches |
| Q37621777 | Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis |
| Q42363361 | Cell adhesion molecule CD44: its functional roles in prostate cancer. |
| Q34506057 | Cell specific CD44 expression in breast cancer requires the interaction of AP-1 and NFκB with a novel cis-element |
| Q28066285 | Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion |
| Q35832214 | Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer |
| Q28083115 | Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target |
| Q54494155 | Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation. |
| Q92535650 | Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer |
| Q48221025 | Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer. |
| Q90054566 | Dual Loading of Nanoparticles with Doxorubicin and Icotinib for the Synergistic Suppression of Non-Small Cell Lung Cancer |
| Q92645951 | Dysregulation of CD44v6 may lead to recurrent spontaneous abortion by inhibiting the proliferation and migration of trophoblast cells |
| Q39109931 | EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression |
| Q37289163 | ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis |
| Q36014258 | Effects of hypoxia and its relationship with apoptosis, stem cells, and angiogenesis on the thymus of children with congenital heart defects: a morphological and immunohistochemical study |
| Q28247479 | Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules |
| Q39135548 | Evaluating stem and cancerous biomarkers in CD15+CD44+ KYSE30 cells. |
| Q92618096 | Evaluation of the correlativity of gender determining region Y-box 4, N-cadherin, CD44 and E-cadherin expression in the prognosis of esophageal squamous cell carcinoma |
| Q42259209 | Expression of CD44v6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma |
| Q37250469 | Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma |
| Q42274896 | Extranodal nasal NK/T-cell lymphoma: a rare oral presentation and FASN, CD44 and GLUT-1 expression. |
| Q34688048 | FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism. |
| Q36334761 | Formation of spherical cancer stem-like cell colonies with resistance to chemotherapy drugs in the human malignant fibrous histiocytoma NMFH-1 cell line |
| Q36534930 | Frontiers in Suicide Gene Therapy of Cancer |
| Q60303129 | Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44-/- tumor cells, MEFs and macrophages |
| Q35752214 | Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene Networks |
| Q26769960 | Guardian of Genetic Messenger-RNA-Binding Proteins |
| Q24294210 | Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1) |
| Q39919533 | Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities |
| Q35194441 | Hyaluronan-CD44 interactions as potential targets for cancer therapy. |
| Q37649833 | Hyaluronan: a simple polysaccharide with diverse biological functions. |
| Q38176587 | Hyaluronan: towards novel anti-cancer therapeutics |
| Q36201940 | Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. |
| Q38073724 | Hypotheses on the evolution of hyaluronan: a highly ironic acid |
| Q51326636 | Immunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance. |
| Q28482047 | In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147 |
| Q27021261 | Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer |
| Q37634379 | Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms |
| Q34029050 | Interstitial guidance of cancer invasion |
| Q60922966 | LXRα Promotes the Differentiation of Human Gastric Cancer Cells through Inactivation of Wnt/β-catenin Signaling |
| Q26782792 | Lipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and Cancer |
| Q38889576 | Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs. |
| Q52571052 | Lung cancer stem cells-origin, characteristics and therapy. |
| Q89696675 | Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts |
| Q28282509 | Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion |
| Q36261700 | Metastatic and prognostic factors in patients with alveolar echinococcosis |
| Q53059940 | MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. |
| Q57041647 | Multivalent and multifunctional polysaccharide-based particles for controlled receptor recognition |
| Q38727337 | Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma. |
| Q34147649 | Oral epithelial stem cells - implications in normal development and cancer metastasis |
| Q34440780 | PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow |
| Q55280786 | PanCD44 Immunohistochemical Evaluation in Prostatectomies from Patients with Adenocarcinoma. |
| Q39090430 | Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM. |
| Q84972261 | Potential role of serum level of soluble CD44 and IFN-γ in B-cell chronic lymphocytic leukemia |
| Q47156631 | Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer. |
| Q37698959 | Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studies |
| Q37738137 | Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma |
| Q36866015 | Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma |
| Q33922745 | Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas. |
| Q37402928 | Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment |
| Q27013843 | Prostate cancer relevant antigens and enzymes for targeted drug delivery |
| Q35375667 | Proteomic biosignatures for monocyte-macrophage differentiation. |
| Q33758420 | Proteomic identification of CD44 interacting proteins |
| Q38075424 | Redox regulation in stem-like cancer cells by CD44 variant isoforms. |
| Q35746730 | Revealing the Mechanisms of Protein Disorder and N-Glycosylation in CD44-Hyaluronan Binding Using Molecular Simulation |
| Q36394240 | Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal |
| Q37476480 | Review paper: Implications of the "cancer stem cell" hypothesis on murine models of colon cancer and colitis-associated cancer |
| Q38770102 | Role of Pericellular Matrix in the Regulation of Cancer Stemness |
| Q37209539 | Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer |
| Q24307954 | Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme |
| Q26786042 | Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis |
| Q38885517 | SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells |
| Q36014411 | Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity |
| Q58711755 | Significance of Glioma Stem-Like Cells in the Tumor Periphery That Express High Levels of CD44 in Tumor Invasion, Early Progression, and Poor Prognosis in Glioblastoma |
| Q39491891 | Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells |
| Q34719626 | Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44. |
| Q38041726 | Stem-like cells and therapy resistance in squamous cell carcinomas |
| Q27690668 | Structural basis of DDB1-and-Cullin 4-associated Factor 1 (DCAF1) recognition by merlin/NF2 and its implication in tumorigenesis by CD44-mediated inhibition of merlin suppression of DCAF1 function |
| Q36535407 | Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer. |
| Q60956875 | Targeting Cancer Stem Cells to Overcome Chemoresistance |
| Q49544368 | Targeting Stemness: Implications for Precision Medicine in Breast Cancer |
| Q27333471 | Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model |
| Q34781888 | The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? |
| Q34606294 | The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway |
| Q57203761 | The perivascular niche governs an autoregulatory network to support breast cancer metastasis |
| Q38339732 | The potential of CD44 as a diagnostic and prognostic tool in oral cancer |
| Q33507242 | Thymocyte expansion and maturation: crosstalk of CD44v6 on thymocytes and panCD44 on stroma cells |
| Q38884858 | Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity |
| Q35832351 | Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer |
| Q26786070 | Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery |
| Q38820117 | Visualization of CD44 and CD133 in normal pancreas and pancreatic ductal adenocarcinomas: non-overlapping membrane expression in cell populations positive for both markers |
| Q84142688 | [Hyaluronic acid and immunity] |
| Q38775354 | miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation. |
| Q37278515 | sCD44 overexpression increases intraocular pressure and aqueous outflow resistance |
| Q58709246 | ΔNp63 regulates the expression of hyaluronic acid-related genes in breast cancer cells |
| Q47433240 | ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. |
Search more.